Malignant mixed epithelial and mesenchymal tumor of cervix uteri

Summary

Malignant mixed epithelial and mesenchymal tumor of cervix uteri (MONDO:0016277) is a cancer. A subtype of cervical cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	malignant mixed epithelial and mesenchymal tumor of cervix uteri
Mondo ID	MONDO:0016277
Orphanet	213782
NCIT	C40228
UMLS	C5679806
MedGen	1843195
GARD	0020490
Is cancer (heuristic)	yes

Also known as: cervical malignant mixed epithelial and mesenchymal tumor · cervical malignant mixed epithelial and mesenchymal tumour · mixed epithelial and mesenchymal cancer of cervix uteri

Disease family

This is a subtype of cervical cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › reproductive system cancer › female reproductive organ cancer › uterine cancer › cervical cancer › malignant mixed epithelial and mesenchymal tumor of cervix uteri

Related subtypes (8): cervix melanoma, uterine ligament cancer, cervical carcinoma, cervical Wilms tumor, high-grade neuroendocrine carcinoma of the cervix uteri, sarcoma of cervix uteri, malignant germ cell tumor of cervix uteri, malignant neoplasm of endocervix

Subtypes (2): cervical adenosarcoma, cervical carcinosarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.